Evidence map›Paper›PMID 36893979›Full record

ArticleOsteoarthritis and cartilage2023

Evaluating Osteoarthritis Management Programs: outcome domain recommendations from the OARSI Joint Effort Initiative.

K D Allen, K Huffman, R J Cleveland, M van der Esch, J H Abbott, A Abbott, K Bennell, J L Bowden, J Eyles, E L Healey and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Osteoarthritis and cartilage, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

K D AllenDepartment of Medicine & Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA; Durham Department of Veterans Affairs Health Care System, USA. Electronic address: kdallen@email.unc.edu.
K HuffmanDepartment of Medicine & Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA. Electronic address: Katie_huffman@med.unc.edu.
R J ClevelandDepartment of Medicine & Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA. Electronic address: becki@unc.edu.
M van der EschFaculty of Health, Amsterdam University of Applied Sciences, Reade, Center for Rehabilitation and Rheumatology, Amsterdam, the Netherlands. Electronic address: m.vd.esch@reade.nl.
J H AbbottCentre for Musculoskeletal Outcomes Research, University of Otago Medical School, Dunedin, New Zealand. Electronic address: haxby.abbott@otago.ac.nz.
A AbbottDepartment of Health, Medicine and Caring Sciences, Unit of Physiotherapy, Linköping University, SE 581 83 Linköping, Sweden. Electronic address: allan.abbott@liu.se.
K BennellCentre for Health, Exercise and Sports Medicine, Department of Physiotherapy, University of Melbourne, Melbourne, Australia. Electronic address: k.bennell@unimelb.edu.au.
J L BowdenKolling Institute, Sydney Musculoskeletal Health, The University of Sydney, Sydney, NSW, Australia; Department of Rheumatology, Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: jocelyn.bowden@sydney.edu.au.
J EylesKolling Institute, Sydney Musculoskeletal Health, The University of Sydney, Sydney, NSW, Australia; Department of Rheumatology, Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: jillian.eyles@sydney.edu.au.
E L HealeySchool of Medicine, Primary Care Centre Versus Arthritis, Keele University, UK. Electronic address: e.healey@keele.ac.uk.
M A HoldenSchool of Medicine, Primary Care Centre Versus Arthritis, Keele University, UK. Electronic address: m.holden@keele.ac.uk.
Prakash JayakumarThe Musculoskeletal Institute: Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin, Austin, TX, USA. Electronic address: Prakash.Jayakumar@austin.utexas.edu.
K KoenigDepartment of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin, Austin, TX, USA. Electronic address: Karl.Koenig@austin.utexas.edu.
G LoSection of Immunology, Allergy and Rheumatology, Department of Medicine, Baylor College of Medicine and Center of Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, USA. Electronic address: ghlo@bcm.edu.
E LosinaOrthopedic and Arthritis Center for Outcomes Research (OrACORe), Policy and Innovation EValuation in Orthopedic Treatments (PIVOT) Center, Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: elosina@bwh.harvard.edu.
K MillerDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: Kmiller5@uwhealth.org.
N ØsteråsCenter for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway. Electronic address: nina.osteras@medisin.uio.no.
C PrattPhysiotherapy Department, Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: Carin.pratt@health.nsw.gov.au.
J G QuickeChartered Society of Physiotherapy, Chancery Exchange, London, UK; School of Medicine, Keele University, Keele, UK. Electronic address: j.g.quicke@keele.ac.uk.
S SharmaSchool of Health Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Centre for Pain IMPACT, Neuroscience Research Australia, Sydney, Australia. Electronic address: saurab.sharma@unsw.edu.au.
S T SkouResearch Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark; The Research Unit PROgrez, Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Region Zealand, Slagelse, Denmark. Electronic address: stskou@health.sdu.dk.
A T TveterCenter for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway. Electronic address: a.t.tveter@medisin.uio.no.
A WoolfBone and Joint Research Group, Royal Cornwall Hospital, Truro, UK. Electronic address: anthony.woolf@btinternet.com.
S P YuKolling Institute, Sydney Musculoskeletal Health, The University of Sydney, Sydney, NSW, Australia; Department of Rheumatology, Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: shirleyyu@uni.sydney.edu.au.
R S HinmanCentre for Health, Exercise and Sports Medicine, Department of Physiotherapy, University of Melbourne, Melbourne, Australia. Electronic address: ranash@unimelb.edu.au.

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
UNC Core Center for Clinical ResearchP30AR072580 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Amanda E Nelson · 2019 to 2026
$6.1M
HSR&D Senior Research Career Scientist AwardIK6HX002838 · VA · DURHAM VA MEDICAL CENTER · PI Kelli D. Allen · 2020 to 2026
–
HSRD VA IK6 HX002838NCATS NIH HHS UL1 TR002489NIAMS NIH HHS P30 AR072580
6 · The paper itself

Abstract

objectiveTo develop sets of core and optional recommended domains for describing and evaluating Osteoarthritis Management Programs (OAMPs), with a focus on hip and knee Osteoarthritis (OA).

designWe conducted a 3-round modified Delphi survey involving an international group of researchers, health professionals, health administrators and people with OA. In Round 1, participants ranked the importance of 75 outcome and descriptive domains in five categories: patient impacts, implementation outcomes, and characteristics of the OAMP and its participants and clinicians. Domains ranked as "important" or "essential" by ≥80% of participants were retained, and participants could suggest additional domains. In Round 2, participants rated their level of agreement that each domain was essential for evaluating OAMPs: 0 = strongly disagree to 10 = strongly agree. A domain was retained if ≥80% rated it ≥6. In Round 3, participants rated remaining domains using same scale as in Round 2; a domain was recommended as "core" if ≥80% of participants rated it ≥9 and as "optional" if ≥80% rated it ≥7.

resultsA total of 178 individuals from 26 countries participated; 85 completed all survey rounds. Only one domain, "ability to participate in daily activities", met criteria for a core domain; 25 domains met criteria for an optional recommendation: 8 Patient Impacts, 5 Implementation Outcomes, 5 Participant Characteristics, 3 OAMP Characteristics and 4 Clinician Characteristics.

conclusionThe ability of patients with OA to participate in daily activities should be evaluated in all OAMPs. Teams evaluating OAMPs should consider including domains from the optional recommended set, with representation from all five categories and based on stakeholder priorities in their local context.

Indexed as

Osteoarthritis, HipOsteoarthritis, KneeConsensusDelphi TechniqueHealth PersonnelHumansSurveys and QuestionnairesDelphiImplementationOsteoarthritisOutcomes

Identifiers

PMID36893979
PMCPMC10565839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.